FERMT3 and non-small cell lung carcinoma: As expected, the results indicated that the FERMT1 expression was upregulated, while FERMT2 and FERMT3 were down-regulated in the tissue samples from 30 NSCLC cases (P < 0.05, Fig. 2b).